Belimumab injection
Products billed under this code include Benlysta.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Benlysta.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Benlysta | GlaxoSmithKline LLC | 49401-0101-01 | 12 | $699.996 |
| Benlysta | GlaxoSmithKline LLC | 49401-0102-01 | 40 | $2,333.32 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $58.333 | +$0.037 | 10 MG | Belimumab injection | v1, posted September 17, 2026 |
| 3Q26 | $58.296 | +$1.107 | 10 MG | Belimumab injection | v1, posted September 15, 2026 |
| 2Q26 | $57.189 | +$0.033 | 10 MG | Belimumab injection | v1, posted September 15, 2026 |
| 1Q26 | $57.156 | +$1.088 | 10 MG | Belimumab injection | v1, posted September 15, 2026 |
| 4Q25 | $56.068 | +$0.062 | 10 MG | Belimumab injection | v1, posted September 8, 2026 |
| 3Q25 | $56.006 | +$1.038 | 10 MG | Belimumab injection | v1, posted March 10, 2026 |
| 2Q25 | $54.968 | +$0.06 | 10 MG | Belimumab injection | v1, posted March 10, 2026 |
| 1Q25 | $54.908 | +$0.759 | 10 MG | Belimumab injection | v1, posted December 19, 2025 |
| 4Q24 | $54.149 | +$0.02 | 10 MG | Belimumab injection | v1, posted June 11, 2025 |
| 3Q24 | $54.129 | +$0.027 | 10 MG | Belimumab injection | v1, posted June 11, 2025 |
| 2Q24 | $54.102 | +$2.104 | 10 MG | Belimumab injection | v1, posted March 11, 2025 |
| 1Q24 | $51.998 | +$0.028 | 10 MG | Belimumab injection | v1, posted December 19, 2024 |
| 4Q23 | $51.97 | +$1.043 | 10 MG | Belimumab injection | v1, posted October 10, 2024 |
| 3Q23 | $50.927 | +$0.72 | 10 MG | Belimumab injection | v1, posted June 5, 2024 |
| 2Q23 | $50.207 | +$0.008 | 10 MG | Belimumab injection | v1, posted February 23, 2024 |
| 1Q23 | $50.199 | +$0.729 | 10 MG | Belimumab injection | v1, posted December 6, 2023 |
| 4Q22 | $49.47 | +$0.031 | 10 MG | Belimumab injection | v1, posted June 22, 2023 |
| 3Q22 | $49.439 | +$1.189 | 10 MG | Belimumab injection | v1, posted June 9, 2023 |
| 2Q22 | $48.25 | +$0.017 | 10 MG | Belimumab injection | v1, posted December 14, 2022 |
| 1Q22 | $48.233 | +$0.667 | 10 MG | Belimumab injection | v1, posted June 8, 2022 |
| 4Q21 | $47.566 | −$0.012 | 10 MG | Belimumab injection | v1, posted June 2, 2022 |
| 3Q21 | $47.578 | +$0.704 | 10 MG | Belimumab injection | v1, posted June 2, 2022 |
| 2Q21 | $46.874 | +$0.039 | 10 MG | Belimumab injection | v1, posted March 1, 2022 |
| 1Q21 | $46.835 | – | 10 MG | Belimumab injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.